Fatemah O. Kamel

948 total citations
36 papers, 633 citations indexed

About

Fatemah O. Kamel is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Fatemah O. Kamel has authored 36 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Infectious Diseases. Recurrent topics in Fatemah O. Kamel's work include COVID-19 Clinical Research Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Alzheimer's disease research and treatments (3 papers). Fatemah O. Kamel is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Alzheimer's disease research and treatments (3 papers). Fatemah O. Kamel collaborates with scholars based in Saudi Arabia, Egypt and United States. Fatemah O. Kamel's co-authors include Rania Magadmi, Richard Reynolds, Pascal F. Durrenberger, Anna Ettorre, Richard Nicholas, Daniel M. Altmann, Omar Malik, Malcolm J. W. Sim, Rosemary J. Boyton and Abdel‐Moneim M. Osman and has published in prestigious journals such as Blood, BMC Public Health and Frontiers in Pharmacology.

In The Last Decade

Fatemah O. Kamel

33 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemah O. Kamel Saudi Arabia 10 114 100 90 89 68 36 633
Alin Ciobîcă Romania 15 163 1.4× 37 0.4× 90 1.0× 49 0.6× 52 0.8× 52 689
Lekha Saha India 17 273 2.4× 57 0.6× 195 2.2× 51 0.6× 186 2.7× 64 1.4k
Shiyuan Wang China 16 357 3.1× 74 0.7× 25 0.3× 16 0.2× 72 1.1× 55 1.0k
Yumeng Jia China 15 279 2.4× 34 0.3× 30 0.3× 18 0.2× 89 1.3× 128 890
Limei Zhang China 12 219 1.9× 19 0.2× 85 0.9× 50 0.6× 72 1.1× 43 696
Michael Halim China 8 161 1.4× 17 0.2× 36 0.4× 37 0.4× 81 1.2× 21 494
Yanfang Wang China 21 329 2.9× 39 0.4× 47 0.5× 14 0.2× 89 1.3× 104 1.2k
Yijie Wang China 18 289 2.5× 17 0.2× 43 0.5× 32 0.4× 217 3.2× 63 1.1k
Pai‐Feng Kao Taiwan 14 118 1.0× 20 0.2× 13 0.1× 31 0.3× 69 1.0× 21 648
Hiroshi Yamada Japan 15 56 0.5× 42 0.4× 23 0.3× 14 0.2× 36 0.5× 53 603

Countries citing papers authored by Fatemah O. Kamel

Since Specialization
Citations

This map shows the geographic impact of Fatemah O. Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemah O. Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemah O. Kamel more than expected).

Fields of papers citing papers by Fatemah O. Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemah O. Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemah O. Kamel. The network helps show where Fatemah O. Kamel may publish in the future.

Co-authorship network of co-authors of Fatemah O. Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemah O. Kamel. A scholar is included among the top collaborators of Fatemah O. Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemah O. Kamel. Fatemah O. Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamel, Fatemah O., et al.. (2025). Major risk factors underlying the development of metabolic syndrome in vitamin D-deficient rats. Frontiers in Pharmacology. 16. 1573332–1573332.
2.
Magadmi, Rania, et al.. (2024). The protective effect of Astaxanthin on scopolamine - induced Alzheimer’s model in mice. Neurosciences. 29(2). 103–112. 8 indexed citations
3.
Kamel, Fatemah O., et al.. (2024). Agmatine ameliorates diabetes type 2-induced nephropathy in rats. Asian Pacific Journal of Tropical Biomedicine. 14(1). 8–16. 3 indexed citations
4.
Kamel, Fatemah O.. (2023).  Drug-Resistant Epilepsy; An Overview on Management and Treatment. 12(4). 76–90. 1 indexed citations
5.
Magadmi, Rania, et al.. (2023). Polymorphisms in the Drug Transporter Gene ABCB1 Are Associated with Drug Response in Saudi Epileptic Pediatric Patients. Biomedicines. 11(9). 2505–2505. 5 indexed citations
6.
7.
8.
Kamel, Fatemah O., et al.. (2022). Patients’ Perceptions and Satisfaction Regarding Tele-consultations during the COVID-19 Pandemic in Jeddah, Saudi Arabia. Journal of Pharmaceutical Research International. 15–27. 2 indexed citations
9.
Kamel, Fatemah O., et al.. (2021). Evaluation of the Toxicological Profile of Commiphora opobalsamum in Wister Rats for Its Safety and Rational Use. Journal of Pharmaceutical Research International. 31–42. 1 indexed citations
10.
Kamel, Fatemah O., et al.. (2021). Knowledge, Attitude, and Practice of Paracetamol and Ibuprofen Administration Among Caregivers of the Pediatric Age Group in Jeddah. Cureus. 13(1). e12460–e12460. 8 indexed citations
11.
Kamel, Fatemah O., Rania Magadmi, Maha A. Badawi, et al.. (2021). Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: A case control study. Journal of Infection and Public Health. 14(6). 709–716. 5 indexed citations
12.
Alamoudi, Aliaa A., et al.. (2021). Relationship between admission criteria and academic performance in basic science courses in health science colleges in KAU. BMC Medical Education. 21(1). 94–94. 6 indexed citations
13.
Kamel, Fatemah O., et al.. (2021). Pathophysiological Cascade of Events Leading to Epilepsy: Role of Inflammation. Journal of Pharmaceutical Research International. 74–84. 1 indexed citations
14.
Alzahrani, Yahya, et al.. (2020). Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats. Saudi Pharmaceutical Journal. 28(5). 574–581. 21 indexed citations
15.
Osman, Abdel‐Moneim M., Huda Mohammed Alkreathy, Hamdan S. Al-malky, et al.. (2019). Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats. Journal of Pharmaceutical Research International. 1–11. 6 indexed citations
16.
Kamel, Fatemah O., et al.. (2017). Knowledge, attitude, and beliefs toward traditional herbal medicine use among diabetics in Jeddah Saudi Arabia. Complementary Therapies in Clinical Practice. 29. 207–212. 49 indexed citations
17.
Osman, Abdel‐Moneim M., Sameer Alharthi, Huda Mohammed Alkreathy, et al.. (2015). Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals. Cancer Cell International. 15(1). 6–6. 36 indexed citations
18.
Osman, Abdel‐Moneim M., Sameer Alharthi, Mohamed F. Elshal, et al.. (2015). Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells. Cancer Cell International. 15(1). 104–104. 15 indexed citations
19.
Alharthi, Sameer, et al.. (2015). Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia. Saudi Medical Journal. 36(7). 813–820. 18 indexed citations
20.
Durrenberger, Pascal F., Anna Ettorre, Fatemah O. Kamel, et al.. (2012). Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1). Journal of Neuroinflammation. 9(1). 1–1. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alin Ciobîcă Breakdown of academic impact, for papers by Lekha Saha Breakdown of academic impact, for papers by Shiyuan Wang Breakdown of academic impact, for papers by Yumeng Jia Breakdown of academic impact, for papers by Limei Zhang Breakdown of academic impact, for papers by Michael Halim Breakdown of academic impact, for papers by Yanfang Wang Breakdown of academic impact, for papers by Yijie Wang Breakdown of academic impact, for papers by Pai‐Feng Kao Breakdown of academic impact, for papers by Hiroshi Yamada
Rankless by CCL
2026